Recombinant Herpes Zoster Vaccine (CHO Cells)

recombinant herpes zoster vaccine produced in CHO cells · MAXVAX Biotechnology Limited Liability Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant Herpes Zoster Vaccine (CHO Cells), covering 2024-11-20 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above [Phase 2]

See pricing